Insulin spending in Massachusetts skyrocketed 50 percent in just three years, according to a new state study. The increase is the latest example of the state’s continued issues around drug spending increases and health care affordability.
The Health Policy Commission analysis was released Wednesday during a hearing, as the independent agency seeks to establish a benchmark for Massachusetts health care spending growth next year.
Despite the state’s previous successes holding down total health…
